Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 281

1.

Targeted tumor cell internalization and imaging of multifunctional quantum dot-conjugated immunoliposomes in vitro and in vivo.

Weng KC, Noble CO, Papahadjopoulos-Sternberg B, Chen FF, Drummond DC, Kirpotin DB, Wang D, Hom YK, Hann B, Park JW.

Nano Lett. 2008 Sep;8(9):2851-7. doi: 10.1021/nl801488u. Epub 2008 Aug 20.

PMID:
18712930
2.

Tumor targeting using anti-her2 immunoliposomes.

Park JW, Kirpotin DB, Hong K, Shalaby R, Shao Y, Nielsen UB, Marks JD, Papahadjopoulos D, Benz CC.

J Control Release. 2001 Jul 6;74(1-3):95-113.

PMID:
11489487
3.

Anti-HER2 immunoliposomes for targeted therapy of human tumors.

Park JW, Hong K, Kirpotin DB, Meyer O, Papahadjopoulos D, Benz CC.

Cancer Lett. 1997 Oct 14;118(2):153-60.

PMID:
9459205
4.

Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models.

Kirpotin DB, Drummond DC, Shao Y, Shalaby MR, Hong K, Nielsen UB, Marks JD, Benz CC, Park JW.

Cancer Res. 2006 Jul 1;66(13):6732-40.

5.

Epidermal growth factor receptor (EGFR)-targeted immunoliposomes mediate specific and efficient drug delivery to EGFR- and EGFRvIII-overexpressing tumor cells.

Mamot C, Drummond DC, Greiser U, Hong K, Kirpotin DB, Marks JD, Park JW.

Cancer Res. 2003 Jun 15;63(12):3154-61.

6.

Hepatoma cell uptake of cationic multifluorescent quantum dot liposomes.

Bothun GD, Rabideau AE, Stoner MA.

J Phys Chem B. 2009 Jun 4;113(22):7725-8. doi: 10.1021/jp9017458.

PMID:
19473036
7.

Functionalized-quantum-dot-liposome hybrids as multimodal nanoparticles for cancer.

Al-Jamal WT, Al-Jamal KT, Bomans PH, Frederik PM, Kostarelos K.

Small. 2008 Sep;4(9):1406-15. doi: 10.1002/smll.200701043.

PMID:
18711753
8.

Targeted cellular delivery of quantum dots loaded on and in biotinylated liposomes.

Sigot V, Arndt-Jovin DJ, Jovin TM.

Bioconjug Chem. 2010 Aug 18;21(8):1465-72. doi: 10.1021/bc100054c.

PMID:
20715851
9.

Imaging epidermal growth factor receptor expression in vivo: pharmacokinetic and biodistribution characterization of a bioconjugated quantum dot nanoprobe.

Diagaradjane P, Orenstein-Cardona JM, Colón-Casasnovas NE, Deorukhkar A, Shentu S, Kuno N, Schwartz DL, Gelovani JG, Krishnan S.

Clin Cancer Res. 2008 Feb 1;14(3):731-41. doi: 10.1158/1078-0432.CCR-07-1958.

10.

Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery.

Park JW, Hong K, Kirpotin DB, Colbern G, Shalaby R, Baselga J, Shao Y, Nielsen UB, Marks JD, Moore D, Papahadjopoulos D, Benz CC.

Clin Cancer Res. 2002 Apr;8(4):1172-81.

11.

Folate-mediated tumor cell uptake of quantum dots entrapped in lipid nanoparticles.

Schroeder JE, Shweky I, Shmeeda H, Banin U, Gabizon A.

J Control Release. 2007 Dec 4;124(1-2):28-34. Epub 2007 Aug 30.

PMID:
17928088
12.

Bio-conjugated luminescent quantum dots of doped ZnS: a cyto-friendly system for targeted cancer imaging.

Manzoor K, Johny S, Thomas D, Setua S, Menon D, Nair S.

Nanotechnology. 2009 Feb 11;20(6):065102. doi: 10.1088/0957-4484/20/6/065102. Epub 2009 Jan 14.

PMID:
19417370
13.

Tumor-targeted PE38KDEL delivery via PEGylated anti-HER2 immunoliposomes.

Gao J, Zhong W, He J, Li H, Zhang H, Zhou G, Li B, Lu Y, Zou H, Kou G, Zhang D, Wang H, Guo Y, Zhong Y.

Int J Pharm. 2009 Jun 5;374(1-2):145-52. doi: 10.1016/j.ijpharm.2009.03.018. Epub 2009 Mar 24.

PMID:
19446771
14.

Atomic force microscopy-based cell nanostructure for ligand-conjugated quantum dot endocytosis.

Pan YL, Cai JY, Qin L, Wang H.

Acta Biochim Biophys Sin (Shanghai). 2006 Sep;38(9):646-52.

15.

Clathrin-mediated endocytosis of quantum dot-peptide conjugates in living cells.

Anas A, Okuda T, Kawashima N, Nakayama K, Itoh T, Ishikawa M, Biju V.

ACS Nano. 2009 Aug 25;3(8):2419-29. doi: 10.1021/nn900663r.

PMID:
19653641
16.

Quantum-dot based nanoparticles for targeted silencing of HER2/neu gene via RNA interference.

Tan WB, Jiang S, Zhang Y.

Biomaterials. 2007 Mar;28(8):1565-71. Epub 2006 Dec 11.

PMID:
17161865
17.

Single chain anti-c-Met antibody conjugated nanoparticles for in vivo tumor-targeted imaging and drug delivery.

Lu RM, Chang YL, Chen MS, Wu HC.

Biomaterials. 2011 Apr;32(12):3265-74. doi: 10.1016/j.biomaterials.2010.12.061.

PMID:
21306768
18.

Future directions of liposome- and immunoliposome-based cancer therapeutics.

Park JW, Benz CC, Martin FJ.

Semin Oncol. 2004 Dec;31(6 Suppl 13):196-205. Review.

PMID:
15717745
19.

Quantum dot-aptamer conjugates for synchronous cancer imaging, therapy, and sensing of drug delivery based on bi-fluorescence resonance energy transfer.

Bagalkot V, Zhang L, Levy-Nissenbaum E, Jon S, Kantoff PW, Langer R, Farokhzad OC.

Nano Lett. 2007 Oct;7(10):3065-70. Epub 2007 Sep 14.

PMID:
17854227
20.

Convection-enhanced delivery of targeted quantum dot-immunoliposome hybrid nanoparticles to intracranial brain tumor models.

Weng KC, Hashizume R, Noble CO, Serwer LP, Drummond DC, Kirpotin DB, Kuwabara AM, Chao LX, Chen FF, James CD, Park JW.

Nanomedicine (Lond). 2013 Dec;8(12):1913-25. doi: 10.2217/nnm.12.209. Epub 2013 Apr 30.

PMID:
23631502

Supplemental Content

Support Center